AP - The first vaccine against cervical cancer will be available to girls as young as 9 later this month. Its manufacturer, Merck & Co. Inc., is already taking orders for Gardasil. The three-shot series costs $360.

Reuters - German drugs and chemicals group Merck KGaA has raised its holding in rival Schering AG to just over 10 percent, threatening a planned takeover of Schering by Bayer AG.

AFP - US drug regulators approved the first vaccine against cervical cancer, which kills some 233,000 women worldwide each year.

The U.S. Food and Drug Administration on Thursday approved the first vaccine for cervical cancer -- Gardasil, manufactured by Merck and Co.

AP - Women for the first time have a vaccine to protect themselves against cervical cancer. The Food and Drug Administration on Thursday licensed the vaccine, Gardasil, for use in girls and women ages 9 to 26.

AFP - US federal regulators said they have approved the sale of Gardasil, the first vaccine against cervical cancer, made by US pharmaceutical firm Merck.

The U.S. Food and Drug Administration on Thursday approved the first vaccine for cervical cancer -- Gardasil, manufactured by Merck and Co.

Reuters - A new Merck & Co. Inc. vaccine to prevent a sexually transmitted infection that causes cervical cancer won U.S. approval on Thursday, the company said in a statement.

AP - A new and more potent version of the chickenpox vaccine has won federal approval to prevent shingles, the often excruciatingly painful disease that can strike the elderly when the chickenpox virus emerges after lying dormant for decades.

The Federal Drug Administration (FDA) approved the licensing of Zostavax (Merck & Co., Inc., Whitehouse Station, NJ) on May 25. Zostavax is a new vaccine for shingles (also known as herpes zoster) to be given to people who are at...

AP - A new vaccine that could put the pox on shingles for many adult sufferers of the often painful infection caused by the chickenpox virus has received federal approval, health officials said Friday.

Reuters - Merck & Co. said on Friday that U.S. regulators have approved its vaccine to prevent shingles, a painful disease characterized by a blistering rash.

Reuters - Merck & Co. Inc.'s vaccine to prevent the world's most prevalent sexually transmitted infection sailed through a panel of U.S. health experts, despite early fears of opposition from the Christian Right that it might lead to promiscuity and a false sense of security.

Reuters - Merck & Co. Inc.'s vaccine to prevent the world's most prevalent sexually transmitted infection sailed through a panel of U.S. health experts, despite early fears of opposition from the Christian Right that it might lead to promiscuity and a false sense of security.

Reuters - Merck & Co. Inc.'s vaccine to prevent the world's most prevalent sexually transmitted infection sailed through a panel of U.S. health experts, despite early fears of opposition from the Christian Right that it might lead to promiscuity and a false sense of security.

AP - A drug company hopes to win federal approval early next month for a novel cervical cancer vaccine that it touts as the next biggest thing since the pap test in fighting the No. 2 cancer in women.

AP - A vaccine with the potential to slash worldwide deaths from cervical cancer, the No. 2 cancer killer in women, should be approved for sales in the United States, a federal panel said Thursday.

AP - Unpublished data from the Merck & Co. study that led the drugmaker to halt sales of Vioxx appear to show the blockbuster painkiller raised the risk of heart attack and stroke within just a few months — not after at least 18 months' use, as Merck has consistently argued.

A potent antibiotic which kills different types of bacteria has been discovered by scientists. BBC reports that researchers, from the drug company Merck, isolated platensimycin from a sample of South African soil. More significantly it showed...

Reuters - The first vaccine to protect young women and girls from a sexually transmitted virus that causes cervical cancer won unanimous support from U.S. advisers on Thursday, making approval likely next month.